Islet Sciences, Inc., a biotechnology company engaged in the research, development and commercialization of patented technologies in the field of transplantation therapy for patients with diabetes, today announced that it has exclusively licensed technology from Winthrop University Hospital. This technology is complimentary to the early Beta cell destruction diagnostic that Islet Sciences licensed last month.
URL: http://www.news-medical.net/news/20120910/Islet-Sciences-licenses-noninvasive-technology-for-detecting-Beta-cell-death-from-Winthrop.aspx
No comments:
Post a Comment